PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+36.97%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
(+3.3%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-15.71%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
100
New
16
Increased
29
Reduced
38
Closed
17
Top Buys
| 1 |
Schrodinger
SDGR
|
$8.4M |
| 2 |
Arrowhead Research
ARWR
|
$5.15M |
| 3 |
DexCom
DXCM
|
$4.42M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$4.26M |
| 5 |
Avantor
AVTR
|
$4.25M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$12.7M |
| 2 |
Merck
MRK
|
$10.4M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$9.03M |
| 4 |
Masimo
MASI
|
$8.26M |
| 5 |
Edwards Lifesciences
EW
|
$6.56M |
Sector Composition
| 1 | Healthcare | 92.05% |
| 2 | Technology | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sutro Biopharma
STRO
$72.7M
| $5.79M | 1.48% | 266,645 +56,645 | +27% | +$1.23M |
|
27
Immunic
IMUX
$80.9M
| $5.61M | 1.44% | 366,691 -33,332 | -8% | -$510K |
|
|
ITMR
28
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $5.61M | 1.44% | 282,327 +1,627 | +0.6% | +$32.3K |
|
29
Xenon Pharmaceuticals
XENE
$2.98B
| $5.56M | 1.43% | 361,689 -103,136 | -22% | -$1.59M |
|
30
BridgeBio Pharma
BBIO
$9.89B
| $5.42M | 1.39% | 76,143 +915 | +1% | +$65.1K |
|
|
NUAN
31
DELISTED
Nuance Communications, Inc.
NUAN
| $5.1M | 1.31% | 115,662 -44,413 | -28% | -$1.96M |
|
32
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.7M | 1.2% | 36,161 +5,298 | +17% | +$689K |
|
|
33
Edwards Lifesciences
EW
$47.8B
| $4.62M | 1.18% | 50,584 -71,947 | -59% | -$6.56M |
|
34
InfuSystem Holdings
INFU
$220M
| $4.54M | 1.16% | 241,511 +8,576 | +4% | +$161K |
|
|
SILK
35
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $4.27M | 1.09% | 67,854 -52,161 | -43% | -$3.28M |
|
|
36
Ionis Pharmaceuticals
IONS
$6.79B
| $4.26M | 1.09% | +75,418 | New | +$4.26M |
|
|
37
Avantor
AVTR
$9.18B
| $4.25M | 1.09% | +150,872 | New | +$4.25M |
|
38
KORU Medical Systems
KRMD
$195M
| $4.22M | 1.08% | 701,259 +70,033 | +11% | +$422K |
|
39
Axogen
AXGN
$743M
| $4.13M | 1.06% | 230,509 +105,509 | +84% | +$1.89M |
|
40
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.01M | 1.03% | 538,370 -262,370 | -33% | -$1.95M |
|
|
KDMN
41
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.88M | 0.99% | 934,364 +59,214 | +7% | +$246K |
|
42
Novavax
NVAX
$1.21B
| $3.85M | 0.99% | 34,498 +16,998 | +97% | +$1.9M |
|
43
Idexx Laboratories
IDXX
$51.8B
| $3.8M | 0.97% | 7,593 +93 | +1% | +$46.5K |
|
44
Gossamer Bio
GOSS
$562M
| $3.39M | 0.87% | +350,779 | New | +$3.39M |
|
45
Stereotaxis
STXS
$261M
| $3.3M | 0.84% | 647,543 +3,730 | +0.6% | +$19K |
|
46
Mersana Therapeutics
MRSN
$36.5M
| $3.27M | 0.84% | 123,031 -17,035 | -12% | -$453K |
|
|
ONEM
47
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $3.27M | 0.84% | +75,000 | New | +$3.27M |
|
48
Health Catalyst
HCAT
$239M
| $3.27M | 0.84% | +75,000 | New | +$3.27M |
|
49
AbbVie
ABBV
$372B
| $3.22M | 0.82% | 30,000 -45,008 | -60% | -$4.82M |
|
50
Maravai LifeSciences
MRVI
$350M
| $3.09M | 0.79% | +110,276 | New | +$3.09M |
|